Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 6,859 | 4,633 | 6,705 | 3,346 | 763 |
| Cost of Goods | N/A | N/A | 41 | 37 | 4 |
| Gross Profit | 6,859 | 4,633 | 6,664 | 3,309 | 760 |
| Operating Expenses | 20,441 | 16,367 | 21,137 | 27,907 | 24,716 |
| Operating Income | -13,582 | -11,734 | -14,432 | -24,561 | -23,953 |
| Other Income | 379 | 240 | 603 | 1,808 | 1,978 |
| Pre-tax Income | -13,204 | -11,494 | -13,829 | -22,753 | -21,975 |
| Net Income Continuous | -13,204 | -11,494 | -13,829 | -22,753 | -21,975 |
| Net Income | $-13,204 | $-12,670 | $-13,829 | $-22,753 | $-21,975 |
| EPS Basic Total Ops | -32.40 | -36.00 | -41.40 | -70.19 | -75.59 |
| EPS Basic Continuous Ops | -32.57 | -32.40 | -41.40 | -70.19 | -75.42 |
| EPS Diluted Total Ops | -32.40 | -36.00 | -41.40 | -70.19 | -75.59 |
| EPS Diluted Continuous Ops | -32.57 | -32.40 | -41.40 | -70.19 | -75.42 |
| EBITDA(a) | $-12,194 | $-10,207 | $-12,810 | $-22,304 | $-22,642 |